0001213900-23-077846.txt : 20230920 0001213900-23-077846.hdr.sgml : 20230920 20230920063005 ACCESSION NUMBER: 0001213900-23-077846 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230920 DATE AS OF CHANGE: 20230920 EFFECTIVENESS DATE: 20230920 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aditxt, Inc. CENTRAL INDEX KEY: 0001726711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823204328 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-492527 FILM NUMBER: 231265275 BUSINESS ADDRESS: STREET 1: 737 N. FIFTH STREET, SUITE 200 CITY: RICHMOND STATE: VA ZIP: 23219 BUSINESS PHONE: 909-488-0844 MAIL ADDRESS: STREET 1: 737 N. FIFTH STREET, SUITE 200 CITY: RICHMOND STATE: VA ZIP: 23219 FORMER COMPANY: FORMER CONFORMED NAME: Aditx Therapeutics, Inc. DATE OF NAME CHANGE: 20201113 FORMER COMPANY: FORMER CONFORMED NAME: ADiTx Therapeutics, Inc. DATE OF NAME CHANGE: 20171229 D 1 primary_doc.xml X0708 D LIVE 0001726711 Aditxt, Inc. 737 N. FIFTH STREET SUITE 200 RICHMOND VA VIRGINIA 23219 (650) 870-1200 DELAWARE None Aditx Therapeutics, Inc. ADiTx Therapeutics, Inc. Corporation true Amro Albanna 757 N. FIFTH STREET SUITE 200 RICHMOND VA VIRGINIA 23219 Executive Officer Director Chief Executive Officer Corinne Pankovcin 757 N. FIFTH STREET SUITE 200 RICHMOND VA VIRGINIA 23219 Executive Officer Chief Commercialization Officer Shahrokh Shabahang 757 N. FIFTH STREET SUITE 200 RICHMOND VA VIRGINIA 23219 Executive Officer Director Chief Innovation Officer Rowena Albanna 757 N. FIFTH STREET SUITE 200 RICHMOND VA VIRGINIA 23219 Executive Officer Chief Operating Officer Thomas J. Farley 757 N. FIFTH STREET SUITE 200 RICHMOND VA VIRGINIA 23219 Executive Officer Chief Financial Officer Brian Brady 757 N. FIFTH STREET SUITE 200 RICHMOND VA VIRGINIA 23219 Director Namvar Kiaie 757 N. FIFTH STREET SUITE 200 RICHMOND VA VIRGINIA 23219 Director Jeffrey W. Runge 757 N. FIFTH STREET SUITE 200 RICHMOND VA VIRGINIA 23219 Director Biotechnology Decline to Disclose 06b false 2023-09-06 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 4TH FLOOR NEW YORK NY NEW YORK 10022 NY NEW YORK false 10000000 10000000 0 false 1 775000 true 0 436284 Represents payment of voluntarily deferred payroll to executive officers. false Aditxt, Inc. /s/ Amro Albanna Amro Albanna Chief Executive Officer & Director 2023-09-20